Table 5.
Reporting of details on DMCs in trials that mentioned DMCs (n = 89)
| Parameter | Pediatric Journals (n = 26) |
General Journals (n = 63) |
|---|---|---|
| Members Identity | ||
| Reported | 16 (62) | 51 (81) |
| Unclear or Not Reported | 10 (38) | 12 (19) |
| Member Affiliations | ||
| Reported | 6 (23) | 19 (30) |
| Unclear or Not Reported | 20 (77) | 44 (70) |
| Independence | ||
| Reported | 10 (39) | 23 (37) |
| Unclear or Not Reported | 16 (61) | 40 (63) |
| Monitored outcomes | ||
| Reported | 11 (42) | 39 (62) |
| Unclear or Not Reported | 15 (58) | 24 (38) |
| Vigilance of other trial conduct parameters | ||
| Reported | 5 (9) | 12 (19) |
| Unclear or Not Reported | 21 (81) | 51 (81) |
| Blinding to Primary Outcome Data | ||
| Reported | 7 (27) | 18 (29) |
| Unclear or Not Reported | 19 (73) | 45 (71) |
| Predefined Stopping Guidelines | ||
| Reported | 5 (19) | 18 (29) |
| Unclear or Not Reported | 21 (81) | 45 (71) |
N (%)